Skip to main content
ADTX
NASDAQ Life Sciences

Aditxt Adjourns Special Meeting to Vote on Reverse Split, Dilutive Issuances, and Name Change

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
9
Price
$0.82
Mkt Cap
$456.674K
52W Low
$0.704
52W High
$4,463.46
Market data snapshot near publication time

Summary

Aditxt, Inc. adjourned its special meeting of stockholders until February 13, 2026, to allow more time for voting on proposals including significant dilutive share issuances, a reverse stock split, and a company name change.


Key Events

  • Special Meeting Adjourned

    The special meeting of stockholders was adjourned until February 13, 2026, to allow additional time for voting on key proposals.

  • Potential Significant Dilution

    Shareholders will vote on approving the issuance of common stock underlying Series A-1 and Series C-1 Convertible Preferred Stock and various common stock purchase warrants issued in 2023 and 2024.

  • Massive Increase in Equity Incentive Plan Shares

    A proposal seeks to amend the 2021 Omnibus Equity Incentive Plan to increase the number of shares issuable thereunder from 3 to 350,000, representing a substantial portion of the company's current market capitalization.

  • Reverse Stock Split Proposal

    Stockholders will consider granting discretionary authority to the board for a reverse stock split at a ratio between 1-for-5 and 1-for-250, likely aimed at regaining Nasdaq compliance following a recent extension.


Analysis

Aditxt, Inc. has adjourned its special meeting of stockholders to allow more time for voting on several critical proposals. These proposals include significant potential dilution from the issuance of common stock underlying previously issued convertible preferred stock and warrants, as well as a substantial increase in the shares available under the equity incentive plan. Most notably, shareholders will vote on a reverse stock split with a wide ratio range (1:5 to 1:250), which is a common strategy for micro-cap companies to regain compliance with Nasdaq's minimum bid price requirement, especially following the recent Nasdaq extension granted to the company. The proposed name change to 'bitXbio, Inc.' could signal a strategic pivot or an attempt to rebrand. The combination of these proposals indicates the company is taking drastic measures to address its financial and listing challenges, which carries high risk for existing shareholders due to the potential for significant dilution and the negative implications often associated with reverse stock splits.

At the time of this filing, ADTX was trading at $0.82 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $456.7K. The 52-week trading range was $0.70 to $4,463.46. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ADTX - Latest Insights

ADTX
Jun 11, 2026, 3:09 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $0.0124
Real-time Price: $0.0143 info
Change: +$0.0019 (+15%) info
Market Cap: $10.362K info
ADTX
Jun 10, 2026, 5:30 PM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $0.0189
Real-time Price: $0.0143 info
Change: -$0.0046 (-24%) info
Market Cap: $10.362K info
ADTX
Jun 10, 2026, 3:13 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $0.029
Real-time Price: $0.0143 info
Change: -$0.0147 (-51%) info
Market Cap: $10.362K info
ADTX
Jun 09, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.033
Real-time Price: $0.0143 info
Change: -$0.0187 (-57%) info
Market Cap: $10.362K info
ADTX
Jun 09, 2026, 7:45 AM EDT
Source: Dow Jones Newswires
Importance Score:
10
Price at Filing: $0.04803
Real-time Price: $0.0143 info
Change: -$0.03373 (-70%) info
Market Cap: $10.362K info
ADTX
Jun 05, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.0597
Real-time Price: $0.0143 info
Change: -$0.0454 (-76%) info
Market Cap: $10.362K info
ADTX
Jun 01, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.0999
Real-time Price: $0.0143 info
Change: -$0.0856 (-86%) info
Market Cap: $10.362K info
ADTX
May 29, 2026, 4:21 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.142
Real-time Price: $0.0143 info
Change: -$0.1277 (-90%) info
Market Cap: $10.362K info
ADTX
May 22, 2026, 5:03 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $0.480
Real-time Price: $0.0143 info
Change: -$0.4657 (-97%) info
Market Cap: $10.362K info
ADTX
May 20, 2026, 4:31 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.43
Real-time Price: $0.0143 info
Change: -$1.42 (-99%) info
Market Cap: $10.362K info